158 related articles for article (PubMed ID: 1708296)
1. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.
Oblakowski P; Bello-Fernandez C; Reittie JE; Heslop HE; Galatowicz G; Veys P; Wilkes S; Prentice HG; Hazlehurst G; Hoffbrand AV
Blood; 1991 May; 77(9):1996-2001. PubMed ID: 1708296
[TBL] [Abstract][Full Text] [Related]
2. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
4. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes.
Timonen T; Gahmberg CG; Patarroyo M
Int J Cancer; 1990 Dec; 46(6):1035-40. PubMed ID: 1979068
[TBL] [Abstract][Full Text] [Related]
5. CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.
Komatsu F; Kajiwara M
Oncol Res; 2000; 12(1):17-24. PubMed ID: 11061342
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.
Chong AS; Staren ED; Scuderi P
Cancer Immunol Immunother; 1992; 35(5):335-41. PubMed ID: 1382856
[TBL] [Abstract][Full Text] [Related]
7. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
[TBL] [Abstract][Full Text] [Related]
8. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
[TBL] [Abstract][Full Text] [Related]
10. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH
Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126
[TBL] [Abstract][Full Text] [Related]
11. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
12. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
Savary CA; Lotzová E
Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
[TBL] [Abstract][Full Text] [Related]
14. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM
Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543
[TBL] [Abstract][Full Text] [Related]
15. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
[TBL] [Abstract][Full Text] [Related]
16. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
Bendall LJ; Kortlepel K; Gottlieb DJ
Leukemia; 1995 Apr; 9(4):677-84. PubMed ID: 7723403
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.
Jansen JH; van der Harst D; Wientjens GJ; Kooy-Winkelaar YM; Brand A; Willemze R; Kluin-Nelemans HC
Blood; 1992 Jul; 80(2):478-83. PubMed ID: 1352710
[TBL] [Abstract][Full Text] [Related]
19. Adhesion molecules on freshly recovered T leukemias promote tumor-directed lympholysis.
Schirren CA; Völpel H; Meuer SC
Blood; 1992 Jan; 79(1):138-43. PubMed ID: 1370201
[TBL] [Abstract][Full Text] [Related]
20. Conjugate formation by leukemic blasts from acute myeloid leukemia with cytotoxic lymphocytes.
Palucka AK; Porwit A; Reizenstein P
Leuk Lymphoma; 1993 Nov; 11(5-6):427-33. PubMed ID: 7907248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]